EUVIMEDDescoperă EUVIMED
Open access

Velaglucerase alfa in the treatment of Gaucher disease type 1

Thomas A Burrow, Gregory A Grabowski

Clinical Investigation · 2011

DOI: 10.4155/cli.10.21 ↗

At a glance

Journal article in Clinical Investigation, 2011. Written by Thomas A Burrow and 1 co-authors. Institution: Cincinnati Children's Hospital Medical Center, Division of Human Genetics, 3333 Burnet Avenue, MLC 4006, Cincinnati, OH 45229-43039, USA. Cited 30 times so far (Crossref); 22 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Authors and institutions

  • Cincinnati Children's Hospital Medical Center, Division of Human Genetics, 3333 Burnet Avenue, MLC 4006, Cincinnati, OH 45229-43039, USA.

Funding

  • NIDDK NIH HHS

Cite

APA

Burrow, T. A., & Grabowski, G. A. (2011). Velaglucerase alfa in the treatment of Gaucher disease type 1. Clinical Investigation. https://doi.org/10.4155/cli.10.21

Vancouver

Burrow TA, Grabowski GA. Velaglucerase alfa in the treatment of Gaucher disease type 1. Clinical Investigation. 2011. doi:10.4155/cli.10.21

BibTeX
@article{Burrow2011,
  author = {Burrow, Thomas A and Grabowski, Gregory A},
  title = {Velaglucerase alfa in the treatment of Gaucher disease type 1},
  journal = {Clinical Investigation},
  year = {2011},
  doi = {10.4155/cli.10.21}
}
Start for free →